
Pharma News
-
How to Test and Use Self-testing COVID-19?
2022-03-14Antigen testing can be used as a complementary tool for screening specific populations to improve "early detection". It is not yet clear whether the results of the new crown antigen self-test can be used as proof of travel.
-
The New Crown Antigen Self-Testing Products Were Approved For Marketing Who Can Self-Test?
2022-03-14On March 12, the State Drug Administration (SDA) issued a notice approving the application changes for self-testing applications of new coronary antigen products from where as follows.
-
New Drugs Approved by FDA in February 2022
2022-03-14This drug is Legend Bio's first CAR-T cell therapy, which is of great significance. It was granted orphan drug designation by the US FDA and European EMA in February 2019 and February 2020, respectively.
-
Market Analysis of Veterinary Drug Feed Ingredients - VPi Down
2022-03-09Data monitoring, the veterinary drug raw material price index (VPi) on March 2 was 83.49. The domestic veterinary raw material market lacks confidence, and weak demand is transmitted, mostly showing a wait-and-see attitude.
-
Biogen is Preparing for the Largest Layoff in Company History!
2022-03-04The Nobel Prize-winning biotech company hasn't given up after a 2021 run-in with its new drug Aduhelm, and is still trying to sell the new, controversial Alzheimer's disease treatment, and is battered from setbacks in other businesses recover.
-
Panlong Pharmaceuticals Convertible Bonds Open for Subscription to Accelerate Main Business Expansion and Upgrading
2022-03-04On March 2, the online roadshow for the issuance of convertible bonds of Panlong Pharmaceuticals was successfully held, and the company's convertible bonds are available for subscription today.
-
The First Domestic CAR-T Went Overseas, And The FDA Approved It!
2022-03-01On February 28, the Biologics License Application (BLA) of Legend Bio's CAR-T therapy cilta-cel targeting B cell maturation antigen (BCMA) was officially approved by the FDA for the treatment of relapse/ Patients with refractory multiple myeloma (r/r MM).
-
Years of Low Prices of Powdered Kudzu Root, How Much Room for Future Upside?
2022-03-01In this issue, Tiandi Yuntu Chinese medicine industry big data platform according to production and sales data on the species market for an analysis.
-
Bayer Showcases the Latest Progress in the R&D Pipeline of Prescription Drugs, Promotes Medical Innovation and Facilitates Business Transformation
2022-03-01At its recent Prescription Drugs Global Media Day 2022, Bayer showcased the latest progress in the ongoing transformation of its prescription drug business, which aims to achieve long-term, sustainable business growth by providing patients.
-
The 9.2 billion New Crown Special Medicine Orders Stunned the CDMO Leader, and This Year's Revenue will Surge by 200%?
2022-02-25On the afternoon of February 20, Asymchem issued an announcement that the company continued to provide contract custom development and production (CDMO) services for a small molecule chemical innovative drug of a pharmaceutical company.
-
What range of heart rate is considered normal?
2022-02-21Now many people check in in the circle of friends, and some sports experts have bought devices such as bracelets to measure their heart rate. But do you really know your heart rate?
-
How Much Will ADC Drugs Sell In 2021
2022-02-21As a powerful anti-cancer drug, ADC drug has become another hot research direction after PD-1. From its own principle and structure, it is composed of monoclonal antibody (mAb)
-
$36.781 Billion! Drug King Changed! Cosmic Factory, Pfizer is Back!
2022-02-17Pfizer released its 2021 financial report, in which the revenue of Comirnaty, the mRNA new crown vaccine jointly developed by Pfizer and BioNTech, reached a record $36.781 billion, making it the “King of Medicines”.
-
The 250 Millionth Chemical Is Born!
2022-02-17With the rapid development of life sciences, the beginning of the biological age is slowly unfolding, and this trend is also reflected in the growing content of biological sequences in CAS REGISTRY.
-
Analysis of The Domestic Veterinary Drug Raw Material Market In The Seventh Week of 2022-2
2022-02-17Sulfonamide products run smoothly, and product prices are high. Asia Pacific Yihe Data Analysis Center focuses on products
-
Analysis of The Domestic Veterinary Drug Raw Material Market In The Seventh Week of 2022-1
2022-02-17Ceftiofur sodium, ceftiofur hydrochloride, affected by the production restriction and suspension of Beijing Winter Olympics, the price is strong, ceftiofur sodium 2350, ceftiofur hydrochloride 1700
-
Just Now, Pfizer's Blockbuster Small Molecule New Drug Paxlovid was Urgently Approved in China!
2022-02-16This product is an oral small-molecule novel coronavirus treatment drug for the treatment of adults with mild to moderate novel coronavirus pneumonia (COVID-19) with high risk factors for progression to severe disease.
-
Drug Excipients, Let People Rejoice, Let People Worry
2022-02-15Theoretically, all chemical substances that can affect the organs, physiological functions and cellular metabolic activities of the body belong to the category of drugs.
-
February Market Analysis of Raw Materials for Veterinary Medicines
2022-02-11VPI is stable, the market restarts slowly after the holiday, and a wait-and-see mentality is strong, waiting for changes in the market to choose.
-
Market Analysis of Veterinary Drug Raw Materials
2022-02-11Penicillin industrial salt - quotations from mainstream factories are high, market inquiries increase after the holiday, and trade transaction prices are broad (transaction 115-145 yuan/billion).
-
Pharmaceutical Industry Overview
The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.Published in: Aug. 2024
Hot News
-
Top 10 Global CDMO Rankings in 2022
-
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody
-
Forecast of TOP 10 global best-selling drugs in 2021
-
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
China State Drug Administration officially approved Semaglutide for type 2 diabetes
-
Top 30 best-selling oncology drugs in the world in 2020
-
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan